Literature DB >> 17283212

Trans-acting glmS catalytic riboswitch: locked and loaded.

Rebecca A Tinsley1, Jennifer R W Furchak, Nils G Walter.   

Abstract

A recently discovered class of gene regulatory RNAs, coined riboswitches, are commonly found in noncoding segments of bacterial and some eukaryotic mRNAs. Gene up- or down-regulation is triggered by binding of a small organic metabolite, which typically induces an RNA conformational change. Unique among these noncoding RNAs is the glmS catalytic riboswitch, or ribozyme, found in the 5'-untranslated region of the glmS gene in Gram-positive bacteria. It is activated by glucosamine-6-phosphate (GlcN6P), leading to site-specific backbone cleavage of the mRNA and subsequent repression of the glmS gene, responsible for cellular GlcN6P production. Recent biochemical and structural evidence suggests that the GlcN6P ligand acts as a coenzyme and participates in the cleavage reaction without inducing a conformational change. To better understand the role of GlcN6P in solution structural dynamics and function, we have separated the glmS riboswitch core from Bacillus subtilis into a trans-cleaving ribozyme and an externally cleaved substrate. We find that trans cleavage is rapidly activated by nearly 5000-fold to a rate of 4.4 min(-1) upon addition of 10 mM GlcN6P, comparable to the cis-acting ribozyme. Fluorescence resonance energy transfer suggests that this ribozyme-substrate complex does not undergo a global conformational change upon ligand binding in solution. In addition, footprinting at nucleotide resolution using terbium(III) and RNase V1 indicates no significant changes in secondary and tertiary structure upon ligand binding. These findings suggest that the glmS ribozyme is fully folded in solution prior to binding its activating ligand, supporting recent observations in the crystalline state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17283212      PMCID: PMC1831870          DOI: 10.1261/rna.341807

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  27 in total

1.  Reaction pathway of the trans-acting hepatitis delta virus ribozyme: a conformational change accompanies catalysis.

Authors:  Miguel J B Pereira; Dinari A Harris; David Rueda; Nils G Walter
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

Review 2.  Engineered allosteric ribozymes as biosensor components.

Authors:  Ronald R Breaker
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

3.  Rearrangement of substrate secondary structure facilitates binding to the Neurospora VS ribozyme.

Authors:  Ricardo Zamel; Richard A Collins
Journal:  J Mol Biol       Date:  2002-12-13       Impact factor: 5.469

4.  Diffusely bound Mg2+ ions slightly reorient stems I and II of the hammerhead ribozyme to increase the probability of formation of the catalytic core.

Authors:  David Rueda; Katrin Wick; S Elizabeth McDowell; Nils G Walter
Journal:  Biochemistry       Date:  2003-08-26       Impact factor: 3.162

5.  Use of terbium as a probe of tRNA tertiary structure and folding.

Authors:  M R Hargittai; K Musier-Forsyth
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

6.  Local conformational changes in the catalytic core of the trans-acting hepatitis delta virus ribozyme accompany catalysis.

Authors:  Dinari A Harris; David Rueda; Nils G Walter
Journal:  Biochemistry       Date:  2002-10-08       Impact factor: 3.162

7.  Trans-acting hepatitis delta virus ribozyme: catalytic core and global structure are dependent on the 5' substrate sequence.

Authors:  Sohee Jeong; Jana Sefcikova; Rebecca A Tinsley; David Rueda; Nils G Walter
Journal:  Biochemistry       Date:  2003-07-01       Impact factor: 3.162

8.  Control of gene expression by a natural metabolite-responsive ribozyme.

Authors:  Wade C Winkler; Ali Nahvi; Adam Roth; Jennifer A Collins; Ronald R Breaker
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

9.  Significant kinetic solvent isotope effects in folding of the catalytic RNA from the hepatitis delta virus.

Authors:  Rebecca A Tinsley; Dinari A Harris; Nils G Walter
Journal:  J Am Chem Soc       Date:  2003-11-19       Impact factor: 15.419

10.  Probing RNA structural dynamics and function by fluorescence resonance energy transfer (FRET).

Authors:  Nils G Walter
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2003-02
View more
  32 in total

1.  Protonation states of the key active site residues and structural dynamics of the glmS riboswitch as revealed by molecular dynamics.

Authors:  Pavel Banás; Nils G Walter; Jirí Sponer; Michal Otyepka
Journal:  J Phys Chem B       Date:  2010-07-08       Impact factor: 2.991

2.  An active-site guanine participates in glmS ribozyme catalysis in its protonated state.

Authors:  Júlia Viladoms; Lincoln G Scott; Martha J Fedor
Journal:  J Am Chem Soc       Date:  2011-10-20       Impact factor: 15.419

3.  Use of a coenzyme by the glmS ribozyme-riboswitch suggests primordial expansion of RNA chemistry by small molecules.

Authors:  Adrian R Ferré-D'Amaré
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-10-27       Impact factor: 6.237

4.  Non-nearest-neighbor dependence of the stability for RNA group II single-nucleotide bulge loops.

Authors:  Michael D McCann; Geoffery F S Lim; Michelle L Manni; Julie Estes; Kelly A Klapec; Gregory D Frattini; Robert J Knarr; Jessica L Gratton; Martin J Serra
Journal:  RNA       Date:  2010-11-18       Impact factor: 4.942

Review 5.  Structural features of metabolite-sensing riboswitches.

Authors:  Catherine A Wakeman; Wade C Winkler; Charles E Dann
Journal:  Trends Biochem Sci       Date:  2007-08-30       Impact factor: 13.807

6.  Leakage and slow allostery limit performance of single drug-sensing aptazyme molecules based on the hammerhead ribozyme.

Authors:  Chamaree de Silva; Nils G Walter
Journal:  RNA       Date:  2008-11-24       Impact factor: 4.942

7.  RNA dynamics: it is about time.

Authors:  Hashim M Al-Hashimi; Nils G Walter
Journal:  Curr Opin Struct Biol       Date:  2008-06-09       Impact factor: 6.809

8.  Computational selection and experimental validation of allosteric ribozymes that sense a specific sequence of human telomerase reverse transcriptase mRNAs as universal anticancer therapy agents.

Authors:  Robert Penchovsky; Gergana T Kostova
Journal:  Nucleic Acid Ther       Date:  2013-11-09       Impact factor: 5.486

9.  An in vitro evolved glmS ribozyme has the wild-type fold but loses coenzyme dependence.

Authors:  Matthew W L Lau; Adrian R Ferré-D'Amaré
Journal:  Nat Chem Biol       Date:  2013-10-06       Impact factor: 15.040

Review 10.  The structural and functional diversity of metabolite-binding riboswitches.

Authors:  Adam Roth; Ronald R Breaker
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.